Kabra Drugs Limited (BOM:524322)

Kabra Drugs Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	212.99	26.71	0.03	0.01	0.1
Short-Term Investments	-	0.44	0.44	-	-	-
Cash & Short-Term Investments	212.99	213.43	27.15	0.03	0.01	0.1
Cash Growth	697.43%	686.23%	91932.82%	133.67%	-87.10%	-10.75%
Accounts Receivable	-	6.01	6.01	6	6	12.55
Receivables	-	6.01	6.01	6.44	6.72	13.26
Other Current Assets	-	32.19	12.33	0.33	0.33	0.33
Total Current Assets	-	251.62	45.48	6.8	7.06	13.69
Property, Plant & Equipment	-	0.44	-	-	-	0.1
Other Long-Term Assets	-	0.23	0.23	0.23	0.23	0.23
Total Assets	-	252.29	45.72	7.04	7.3	14.02
Accounts Payable	-	-	-	-	-	1.87
Short-Term Debt	-	4.37	17.09	13.82	10.26	9
Other Current Liabilities	-	1.37	17.8	0.53	0.97	5.22
Total Current Liabilities	-	5.74	34.89	14.35	11.23	16.1
Long-Term Deferred Tax Liabilities	-	0.01	-	-	-	-
Other Long-Term Liabilities	-	-	-0	0	0	-
Total Liabilities	-	5.74	34.89	14.35	11.23	16.1
Common Stock	-	237.08	43.89	43.89	43.89	43.89
Retained Earnings	-	9.47	-58.56	-51.2	-47.82	-45.96
Comprehensive Income & Other	-	-0	25.5	-	-	-
Shareholders' Equity	246.55	246.55	10.83	-7.31	-3.93	-2.08
Total Liabilities & Equity	-	252.29	45.72	7.04	7.3	14.02
Total Debt	4.37	4.37	17.09	13.82	10.26	9
Net Cash (Debt)	208.62	209.06	10.06	-13.79	-10.25	-8.91
Net Cash Growth	2067.25%	1977.87%	-	-	-	-
Net Cash Per Share	13.19	19.13	2.29	-3.14	-2.33	-2.03
Filing Date Shares Outstanding	23.8	23.71	4.39	4.39	4.39	4.39
Total Common Shares Outstanding	23.8	23.71	4.39	4.39	4.39	4.39
Working Capital	-	245.88	10.6	-7.54	-4.16	-2.41
Book Value Per Share	13.15	10.40	2.47	-1.67	-0.90	-0.47
Tangible Book Value	246.55	246.55	10.83	-7.31	-3.93	-2.08
Tangible Book Value Per Share	13.15	10.40	2.47	-1.67	-0.90	-0.47
Machinery	-	0.44	-	1.66	1.66	1.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.